The Pfizer-BioNTech vaccine has now proved to be 95% effective and has met the safety criteria needed for emergency authorisation.
The Pfizer-BioNTech vaccine has now proved to be 95% effective and has met the safety criteria needed for emergency authorisation.
[NFA] Moderna will apply for U.S. and European emergency-use authorization for its COVID-19 vaccine on Monday after full results..
There are currently two COVID-19 vaccines promising results from their Phase 3 trials.
Moderna announced that its vaccine was..